ConductScience.org, home

Paper3237253

Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors.

Wellstein A and 1 other. Naunyn Schmiedebergs Arch Pharmacol, 1988. Cited by 95 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors. Papers, record 3237253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3237253

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complex dose-response curves of atropine in man explained by different functions of M1- and M2-cholinoceptors.
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
95
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wellstein AA
2Pitschner HFH F

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtropineMajor topic
Receptors, CholinergicMajor topic
Adult
Animals
Cattle
Dose-Response Relationship, Drug
Drug Interactions
Electrocardiography
Female
Half-Life
Heart Rate
Humans
In Vitro Techniques
Male
Pirenzepine
Propranolol
Rats
Salivary Glands
Salivation

Source PubMed

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,726,749The parasympathomimetic activity of atropine and atropine methylbromide.Anesthesiology1968https://conductscience.org/library/papers/5726749PubMed
23,546,321Muscarinic receptor subtypes: a critique of the current classification and a proposal for a working nomenclature.J Auton Pharmacol1986https://conductscience.org/library/papers/3546321PubMed
31,245,090Clinical pharmacology and pharmacokinetics of clonidine.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1245090PubMed
41,101,675New observations on the effects of atropine on the sinoatrial and atrioventricular nodes in man.Am J Cardiol1975https://conductscience.org/library/papers/1101675PubMed
52,439,797Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.J Cardiovasc Pharmacol1986https://conductscience.org/library/papers/2439797PubMed
613,862,830Cholinergic activity of atropine.Nature1962https://conductscience.org/library/papers/13862830PubMed
76,489,444Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum.Eur J Pharmacol1984https://conductscience.org/library/papers/6489444PubMed
86,263,176Presynaptic receptors.Annu Rev Pharmacol Toxicol1981https://conductscience.org/library/papers/6263176PubMed
96,895,934Sympathetic Nerve Stimulation on the perfused rat heart. Affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/6895934PubMed
106,941,376EEG and behavioral effects of pirenzepine in normal volunteers.Scand J Gastroenterol Suppl1980https://conductscience.org/library/papers/6941376PubMed
113,971,545The long-term increase of baseline and reflexly augmented levels of human vagal-cardiac nervous activity induced by scopolamine.Circulation1985https://conductscience.org/library/papers/3971545PubMed
127,350,532Pirenzepine distinguishes between different subclasses of muscarinic receptors.Nature1980https://conductscience.org/library/papers/7350532PubMed
136,151,508Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6151508PubMed
146,897,666Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.Life Sci1982https://conductscience.org/library/papers/6897666PubMed
156,941,375Cerebro-spinal fluid concentrations of pirenzepine after therapeutic dosage.Scand J Gastroenterol Suppl1980https://conductscience.org/library/papers/6941375PubMed
162,857,526Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons.Am J Physiol1985https://conductscience.org/library/papers/2857526PubMed
183,838,676Selective labelling of M1-receptors in autonomic ganglia with 3H-pirenzepine.Arzneimittelforschung1985https://conductscience.org/library/papers/3838676PubMed
194,165,436Effects of atropine on heart-rate in healthy man.Lancet1967https://conductscience.org/library/papers/4165436PubMed
2013,465,301Theories of drug antagonism.Pharmacol Rev1957https://conductscience.org/library/papers/13465301PubMed
213,185,747Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/3185747PubMed

See all 27 references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.

PMIDTitleJournalYearIn PapersSource
42,021,843Navigating the Core Challenges of Atropine Therapy in Myopia: A Mechanistic and Clinical Analysis of Dose, Response, and Durability.J Ophthalmol2026https://conductscience.org/library/papers/42021843PubMed
38,764,898Pharmacokinetics and Effects on Saliva Flow of Sublingual and Oral Atropine in Clozapine-Treated and Healthy Adults: An Interventional Cross-Over Study.Psychiatry Clin Psychopharmacol2022https://conductscience.org/library/papers/38764898PubMed
34,712,366Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.EFSA J2021https://conductscience.org/library/papers/34712366PubMed
32,876,732The effect of sublingual atropine sulfate on clozapine-induced hypersalivation: a multicentre, randomised placebo-controlled trial.Psychopharmacology (Berl)2020https://conductscience.org/library/papers/32876732PubMed
27,159,349Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.Curr Eye Res2016https://conductscience.org/library/papers/27159349PubMed
21,306,419Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects.Br J Clin Pharmacol2011https://conductscience.org/library/papers/21306419PubMed
21,198,547Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.Br J Pharmacol2011https://conductscience.org/library/papers/21198547PubMed
18,321,791Effects of fitness and age on the response to vagotonic atropine.Auton Neurosci2008https://conductscience.org/library/papers/18321791PubMed
17,657,478The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/17657478PubMed
16,472,280Effects of atropine and pirenzepine on heart rate turbulence.Ann Noninvasive Electrocardiol2006https://conductscience.org/library/papers/16472280PubMed
11,503,945Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.Clin Auton Res2001https://conductscience.org/library/papers/11503945PubMed
9,651,665Effect of a 'vagomimetic' atropine dose on canine cardiac vagal tone and susceptibility to sudden cardiac death.Clin Auton Res1998https://conductscience.org/library/papers/9651665PubMed
9,435,320Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.J Clin Invest1998https://conductscience.org/library/papers/9435320PubMed
8,800,992Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure.Heart1996https://conductscience.org/library/papers/8800992PubMed
8,751,020Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man.Eur J Clin Pharmacol1995https://conductscience.org/library/papers/8751020PubMed
8,586,025New potential uses for transdermal scopolamine (hyoscine).Drugs1995https://conductscience.org/library/papers/8586025PubMed
8,019,342Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide.Abdom Imaging1994https://conductscience.org/library/papers/8019342PubMed
7,995,316The effects of transdermal scopolamine on autonomic nervous activity during sleep.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7995316PubMed
7,889,577Atropine and succinylcholine: beliefs and controversies in paediatric anaesthesia.Can J Anaesth1995https://conductscience.org/library/papers/7889577PubMed
3,185,747Dose-response curves of pirenzepine in man in relation to M1- and M2-cholinoceptor occupancy.Naunyn Schmiedebergs Arch Pharmacol1988https://conductscience.org/library/papers/3185747PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3237253

GET https://conductscience.org/api/papers/v1/3237253/references?page=2